To improve the health and lives of millions in the Middle East and Africa by promoting and developing the latest, safest and most effective pharmaceutical products in the region; through the introduction of new innovative concepts supported by a state of the art manufacturing facility complying with the FDA, the European and GCC GMP standards and requirements.
To be a Nutraceutical and Pharmaceutical market leader in Middle East and Africa, while being acknowledged among the top 10 leading corporates in the Egyptian pharmaceutical industry.
Dr. Mohsen Shalaby, Former Vice President Of BRISTOL-MYERS SQUIBB (MENA regions), established NERHADOU INTERNATIONAL in 1996.
NERHADOU is Ranked among the top 50 leading corporates for 6 consecutive years out of 1200 Pharmaceutical Corporates in Egypt in terms of Market Share of Pharmaceutical Products’ Domestic Sales (2019).
NERHADOU ’s people have been recruited from a wide range of Multinational Pharmaceutical companies and backgrounds, bringing together a unique collection of skills and resources.